Eyewire headlines are now available as a weekly podcast!
Listen Now
Eyewire News
EyewireTV
Podcast
Arrow
Topics
Events
Subscribe
Menu
Search
Eyewire News
EyewireTV
Podcast
Arrow
Topics
Events
Subscribe
Cataract
Refractive
Retina
Glaucoma
Optometry
Business
Health Care
Residents & Fellows
Cornea
Ophthalmology
Apellis
The Latest News
09.30.2021
Apellis Announces Detailed Results from Phase 3 DERBY and OAKS Studies
Source: Apellis Pharmaceuticals
07.24.2018
Apellis Pharmaceuticals’ APL-2 Receives FDA Fast Track Designation for the Treatment of Patients with GA
Source: Apellis Pharmaceuticals
09.12.2018
Apellis Announces First Patient Dosed in Its Phase 3 Clinical Program for APL-2 in Patients With Geographic Atrophy
Source: Apellis Pharmaceuticals
03.04.2019
Apellis Resumes Dosing in Its Phase 3 Program for Patients with Geographic Atrophy
Source: Apellis Pharmaceuticals
Eyewire headlines are now available as a weekly podcast! Listen Now
